Advising Global Access Diagnostics on Covid-19 test contract
We're delighted to have advised Global Access Diagnostics, the UK pandemic test manufacturer, to enable it to supply rapid antigen Covid-19 test to the UK Government to enable it to meet its commitments to on-going testing.
Mark Radford, Chief Executive Officer of GAD, said:
“The support that we received from EMW on this was first class. With a negotiation that was not always straightforward, and which required a mix of pragmatism and flexibility alongside solid legal advice, Matthew and his team were brilliant. Having now successfully concluded the contract, we look forward to supporting the Government with its plan to deliver millions of high quality Covid-19 rapid antigen tests to the UK population, to help the UK economy continue its recovery, allowing schools to open, workplaces to resume and life to return to something more familiar to us all.”
"The project involved complex negotiations with the Cabinet Office and Department for Health and Social Care."
Matthew Holman, Head of Commercial, Technology & Data at EMW said:
“EMW is thrilled to have supported GAD with this project of huge national significance. Continuous testing is key to restarting life in a post-pandemic world. We commend GAD’s commitment to see Covid-19 tests manufactured here in the UK and it is our hope that increased production of tests is one of many reasons for us all to be increasingly positive about 2021. More tests means greater ability to control the virus, which in turn will help us to reverse the tide of Covid-19.”
Get in touch
If you’d like to find out more about this update please get in touch with Matthew Holman.